| Lucas E. Montarce |
Lucas E. Montarce currently works at Christel House International, Inc., as Director, Eli Lilly & Co., as Chief Financial Officer & Executive Vice President from 2024, and Lilly Research Laboratories, as Chief Financial Officer, Group VP & Controller from 2021. Mr. Montarce also formerly worked at Elanco Animal Health, Inc., as Chief Financial Officer in 2018. Mr. Montarce received his undergraduate degree from The Catholic University of America and Masters Business Admin degree from Universidad del CEMA. |
| Donald A. Zakrowski |
Donald A. Zakrowski currently works at Eli Lilly & Co., as Chief Accounting Officer & Vice President-Finance from 2012. Mr. Zakrowski also formerly worked at PricewaterhouseCoopers LLP, as Senior Manager. |
| Patrik Jonsson |
Patrik Jonsson currently works at Eli Lilly & Co., as Executive VP & President-Lilly International from 2025. Mr. Jonsson also formerly worked at The American Chamber of Commerce in Japan, as Director, Eli Lilly Italia SpA, as President & General Manager, and Lilly USA LLC, as President. Mr. Jonsson received his undergraduate degree from Lund University School of Economics & Management. |
| Eric Dozier |
Eric Dozier currently works at Christian Theological Seminary, Inc., as Director, Center for Leadership Development, Inc., as Director, Indianapolis Airport Authority (Indiana), as Director, and Eli Lilly & Co., as Chief People Officer & Executive Vice President from 1998. Mr. Dozier received his Masters Business Admin degree from Indiana University and undergraduate degree from The Ohio State University. |
| Diogo Rau |
Diogo Rau is the founder of GiftGateway, founded in 1999. Mr. Rau is currently employed at Eli Lilly & Co. as Executive VP, Chief Information & Digital Officer since 2021. Former positions include Senior Director-Information Systems & Technology at Apple, Inc. from 2011 to 2021 and Partner at McKinsey & Co., Inc. from 2003 to 2011. Education includes undergraduate and graduate degrees from Stanford University. |
| David Hyman |
Dr. David Hyman, MD, is a Chief Medical Officer at Eli Lilly & Co. and a Chief Medical Officer at Loxo Oncology, Inc. |
| Thomas Fuchs |
Thomas Fuchs is currently working as the Chief Artificial Intelligence Officer at Eli Lilly & Co. He holds a doctorate degree from the Swiss Federal Institute of Technology and a graduate degree from Graz University of Technology. |
| David A. Ricks |
Mr. David A. Ricks is an Independent Director at Adobe, Inc., a Chairman, President & Chief Executive Officer at Eli Lilly & Co., a Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd., a Chairman & Chief Executive Officer at Eli Lilly Italia SpA, a Chairman-Governors Board at James Whitcomb Riley Children's Foundation, a Member at The Business Council and a Member at The Business Roundtable. He is on the Board of Directors at Adobe, Inc., Pharmaceutical Research & Manufacturers of America and The Central Indiana Corporate Partnership. Mr. Ricks was previously employed as a President by Lilly USA LLC, a President & General Manager by Lilly Industries Shanghai Ltd., a General Manager by Eli Lilly Canada, Inc., a Principal by HP, Inc., a Principal by International Business Machines Corp., and a President by International Federation of Pharmaceutical Manufacturers. He also served on the board at Elanco Animal Health, Inc. and European Federation of Pharmaceutical Industries & Assns. He received his undergraduate degree from Purdue University and an MBA from Indiana University. |
| Daniel M. Skovronsky |
Daniel M. Skovronsky was the founder of Avid Radiopharmaceuticals, Inc. since 2004, holding the title of Chief Executive Officer. Current jobs include Independent Director at Myriad Genetics, Inc. since 2020, Chief Scientific Officer & Executive VP at Eli Lilly & Co. since 2024, Member at the University of Pennsylvania, Member-Governance Board at Indianapolis Museum of Art, Inc., and President, Chief Scientific Officer & Senior VP at Lilly Research Laboratories since 2018. Education history includes a doctorate from the University of Pennsylvania in 2000, an undergraduate degree from Yale University in 1994, and a doctorate from the Perelman School of Medicine in 2001. |
| Edgardo Hernandez |
Edgardo Hernandez is currently working as the President-Manufacturing Operations & Senior VP at Eli Lilly & Co. He started this position in 2021. Prior to his current role, he obtained a graduate degree from North Carolina State University and an undergraduate degree from the University of Puerto Rico. |
| Jon Erik Fyrwald |
Jon Erik Fyrwald currently works at International Flavors & Fragrances, Inc., as Chief Executive Officer & Director from 2024, Syngenta Crop Protection – Soluções Para A Agricultura, Ltda., as Chief Executive Officer, Syngenta Foundation For Sustainable Agriculture, as Chairman & Chief Executive Officer, and various other companies. Mr. Fyrwald also formerly worked at Nalco Co., as Chairman, President & Chief Executive Officer from 2008 to 2011, Nalco Holding Co., as Chairman, President & Chief Executive Officer in 2011, Univar NV, as President & Chief Executive Officer from 2012 to 2016, and various other companies. Mr. Fyrwald received his undergraduate degree in 1981 from the University of Delaware. |
| Mary Lynne Hedley |
Mary Lynne Hedley was the founder of Tesaro, Inc. (2010), holding the title of President, Chief Operating Officer & Director from 2014 to 2020, and Zycos, Inc. (1996), serving as President & Chief Executive Officer from 1996 to 2004. Current jobs include Independent Director at Eli Lilly & Co. (2022), Independent Director at Veeva Systems, Inc. (2019), Director at Millendo Therapeutics US, Inc. (2017), Director at Helsinn Holding SA (2021), Director at Youville Place, Independent Non-Executive Director at Centessa Pharmaceuticals Plc (2021), Director at Women Innovating Together In Healthcare, Director at Youville Assisted Living Residences, Venture Partner at Third Rock Ventures LLC (2023), and Member of The American Association of Immunologists, American Association for the Advancement of Science, American Society of Clinical Oncology, Inc., and The American Association of Cancer Research. Former jobs include Independent Director at Receptos LLC (2014-2015), Independent Director at bluebird bio, Inc. (2017-2019), Independent Director at Millendo Therapeutics, Inc. (2017-2021), Director at Helsinn Healthcare SA (2021-2023), Chief Scientific Officer & Executive VP at MGI PHARMA, Inc. (2004-2008), Chief Scientific Officer & EVP-Operations at Abraxis BioScience, Inc. (2009-2010), Executive Vice President at Eisai Corp. of North America (2008-2009), and General Manager & Senior Vice President at MGI PHARMA Biologics, Inc. Education includes an undergraduate degree from Purdue University (1983) and a doctorate from The University of Texas Southwestern Medical Center (1988). |
| Ralph Alvarez |
Mr. Ralph Alvarez is a Lead Independent Director at Traeger, Inc., an Independent Chairman at First Watch Restaurant Group, Inc., an Independent Director at Lowe's Companies, Inc., an Independent Director at Eli Lilly & Co. and a Member-Presidents Council at University of Miami School of Business. He is on the Board of Directors at Traeger, Inc., Lowe's Companies, Inc. and Eli Lilly & Co. Mr. Alvarez was previously employed as an Independent Director by Realogy Holdings Corp. (NJ), an Executive Chairman by Skylark Co. Ltd. /Old/, a Chairman by Skylark Co., Ltd., a Lead Independent Director by Dunkin' Brands Group, Inc., a President by McDonald’s North America, a President by McDonald's Mexico, a COO & President-Central Division by McDonald's USA LLC, a Regional Director by Chipotle Mexican Grill, Inc., a President, Chief Operating Officer & Director by McDonald's Corp., a Vice President by Wendy’s International, Inc., a Budget Analyst by Burger King Corp., a Partner by Advent International LP, a Managing Director by Burger King España SL, a President by Burger King Restaurants of Canada, Inc., a President by Ronald McDonald House Charities Central West, and a Trustee by The Field Museum of Natural History. He also served on the board at Anywhere Real Estate Group LLC, Dunkin' Brands, Inc., KeyCorp, Fox Cities Performing Arts Center, Inc., National Retail Federation, Inc. and The Presidents Council. He received his undergraduate degree from the University of Miami. |
| Gabrielle G. Greene-Sulzberger |
Gabrielle G. Greene-Sulzberger founded Fontis Partners LP in 2009, where she worked as General Partner from 2009 to 2017. Ms. Greene-Sulzberger also currently works at Sesame Workshop, as Chairman, True Food Kitchen Investco LLC, as Chairman from 2019, auxmoney GmbH, as Chairman, and various other companies. Ms. Greene-Sulzberger also formerly worked at Johnson Products Co., Inc., as Chief Executive Officer from 2011 to 2013, Teneo Holdings LLC, as Chairman-ESG Practice, Teneo Consulting LLC, as Chairman-ESG Practice, and various other companies. Ms. Greene-Sulzberger received her Masters Business Admin degree in 1987 from Harvard Business School, graduate degree from Harvard Law School, and undergraduate degree from Woodrow Wilson School of Public & International Affairs. |
| Jamere Jackson |
Jamere Jackson currently works at Eli Lilly & Co., as Independent Director from 2016, Azaa Investments, Inc., as Director, Youth Villages, Inc., as Director, Future 5, as Director, and AutoZone, Inc., as Chief Financial Officer from 2023. Mr. Jackson also formerly worked at Hibbett, Inc., as Independent Director from 2020 to 2022, First Data Corp., as Principal, GE Aerospace, as Principal from 2004 to 2014, The Hertz Corp., as Chief Financial Officer & Executive Vice President from 2018 to 2020, Procter & Gamble Co., as Principal, Total System Services LLC, as Principal, Yum! Brands, Inc., as Principal, The Nielsen Company (US) LLC, as Chief Financial Officer, Nielsen NV, as Chief Financial Officer, Nielsen Holdings Ltd., as Chief Financial Officer from 2014 to 2018, Unison Industries LLC, as Treasurer, The Nielsen Co. BV, as Chief Financial Officer, GE Aviation Systems LLC, as Senior Executive-Finance from 2007 to 2013, Baker Hughes Energy Services LLC, as VP, Chief Financial Office-Drilling & Surface from 2013 to 2014, and Hertz Global Holdings, Inc., as Chief Financial Officer & Executive Vice President from 2018 to 2020. Mr. Jackson received his undergraduate degree in 1990 from the University of Notre Dame. |
| Katherine Baicker |
Katherine Baicker currently works at Eli Lilly & Co., as Independent Director from 2011, Mayo Clinic, as Trustee from 2019, Council on Foreign Relations, Inc., as Member, American Academy of Arts & Sciences, as Member, National Academy of Medicine (United States), as Member, National Bureau of Economic Research, Inc., as Research Associate, The Chicago Council on Global Affairs, as Trustee, National Opinion Research Center, as Trustee, National Academy of Social Insurance, as Member, The University of Chicago Harris School of Public Policy, as Dean & Professor from 2017, and Harris School of Public Policy Studies, as Dean from 2017. Dr. Baicker also formerly worked at National Institutes of Health, as Chairman-Social Sciences & Population Study, AcademyHealth, as Vice Chairman, The Group Insurance Commission, as Chairman, HMS Holdings Corp., as Independent Director from 2019 to 2021, Dartmouth College, as Associate Professor & Assistant Professor from 1998 to 2005, The Urban Institute, as Trustee, Council of Economic Advisers, as Member from 2005 to 2007, Harvard T.H. Chan School of Public Health, as Professor-Health Economics from 2007 to 2017, and Health Affairs, as Member-Editorial Board. Dr. Baicker received her doctorate degree in 1998 from Harvard University and undergraduate degree in 1993 from Yale University. |
| Juan Ricardo Luciano |
Juan Ricardo Luciano currently works at Archer-Daniels-Midland Co., as Chairman, President & Chief Executive Officer from 2016, Eli Lilly & Co., as Lead Independent Director from 2019, Rush System for Health, as Director, The Business Council, as Director, ADM Grain River System, Inc., as Director from 2012, ADM Clinton BioProcessing, Inc., as Director from 2012, Intersect Illinois, as Director, The Commercial Club of Chicago, as Member, The Business Roundtable, as Member, Dow Hydrocarbons & Resources LLC, as Member, Global Advisory Board, as Member from 2017, and The Economic Club of Chicago, as Member. Mr. Luciano also formerly worked at ADM Alliance Nutrition, Inc., as Director, Wilmar International Ltd., as Non-Executive Director from 2012 to 2022, The Economic Club of Chicago (Illinois), as Director, Kellogg School of Management, as Director, The Dow Chemical Co., as President-Performance Division from 2010 to 2011, Boys & Girls Clubs of America, as Trustee, Rush University Medical Center, as Trustee, and US-China Business Council, as Member. Mr. Luciano received his undergraduate degree from Instituto Tecnológico de Buenos Aires. |
| Jon R. Moeller |
Jon R. Moeller currently works at Procter & Gamble Co., as Chairman, President & Chief Executive Officer from 2022, Procter & Gamble Service GmbH, as Chairman, President & Chief Executive Officer, Procter & Gamble (Manufacturing) Ireland Ltd., as Chief Operating Officer, CFO & Vice Chairman, MDVIP LLC (Florida), as Director, Natura Pet Products, Inc., as Director, The Consumer Goods Forum, as Director, Isle of Harris Distillers Ltd., as Director, Alliance To End Plastic Waste, as Director, The Business Roundtable, as Director, Eli Lilly & Co., as Independent Director from 2024, Commercial Club of Cincinnati, as Trustee, Cincinnati Art Museum, as Vice President, and The Conference Board Council of Financial Executives, as Member. Mr. Moeller also formerly worked at Monsanto Co., as Independent Director from 2011 to 2018 and Visiting Nurse Association, as Trustee. Mr. Moeller received his undergraduate degree in 1986 and Masters Business Admin degree in 1988 from Cornell University. |
| Kimberly H. Johnson |
Kimberly H. Johnson currently works at Eli Lilly & Co., as Independent Director from 2021, Greater Washington Board of Trade, as Director, Share Our Strength, Inc., as Director, Calvert Impact Capital, Inc., as Director, After-School All-Stars, as Director, Planet Works, Inc., as Director, Communities In Schools of The Nations Capital, as Director, T. Rowe Price Group, Inc., as Chief Operating Officer from 2022, and Princeton University, as Trustee. Ms. Johnson also formerly worked at Credit Suisse Group AG, as Director, Credit Suisse (USA) LLC, as Director, Federal National Mortgage Association, as Chief Operating Officer & Executive Vice President from 2018 to 2022, and D.E. Shaw & Co. LLC, as Equity Trader. Ms. Johnson received her undergraduate degree from Princeton University and Masters Business Admin degree from Columbia Business School. |
| William G. Kaelin |
William G. Kaelin is the founder of Tango Therapeutics Sub, Inc. (2017), Cedilla Therapeutics, Inc. (2017), and Tango Therapeutics, Inc. (2017). Current jobs include Independent Director at Eli Lilly & Co. since 2012, Director at The Damon Runyon Cancer Research Foundation, Director at LifeMine Therapeutics, Inc. since 2021, Director at IconOVir Bio, Inc. since 2022, Trustee at Duke University, Professor at Dana-Farber Cancer Institute, Inc., Professor at The Brigham & Women's Hospital, Inc. since 2002, Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the Association of American Physicians, Member of Dana-Farber, Member of the American Society of Clinical Investigation, Professor at Harvard Medical School since 2002, and Advisor at Casdin Capital. Former jobs include Chief Resident & House Officer at The Johns Hopkins Hospital, Inc., Member-Advisory Board at National Cancer Institute, Member at National Academy of Medicine (United States), Member at American College of Physicians, Inc., and Trustee at American Association for Cancer Research. Education includes an undergraduate degree from Duke University, conferred in 1982. |
